Point72 Asset Management’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-14,730
Closed -$379K 3875
2025
Q3
$379K Buy
14,730
+1,465
+11% +$55.3K ﹤0.01% 2002
2025
Q2
$763K Buy
+13,265
New +$1.06M ﹤0.01% 1646
2025
Q1
Sell
-16,172
Closed -$768K 1999
2024
Q4
$768K Buy
+16,172
New +$978K ﹤0.01% 1544
2024
Q1
Sell
-88,000
Closed -$27.6M 2132
2023
Q4
$27.6M Buy
88,000
+71,729
+441% +$26M 0.07% 348
2023
Q3
$7.22M Buy
16,271
+16,236
+46,389% +$7.33M 0.02% 761
2023
Q2
$15.3K Sell
35
-25
-42% -$14.1K ﹤0.01% 1841
2023
Q1
$35.6K Buy
+60
New +$33.6K ﹤0.01% 1850
2022
Q4
Sell
-17,034
Closed -$9.97M 1486
2022
Q3
$9.97M Buy
+17,034
New +$10.2M 0.04% 506

Other funds holding AGL

Point72 Asset Management's AGL Position: Q4 2025 in Review

Point72 Asset Management sold out of Agilon Health (AGL) in Q4 2025, closing a stake of 14,730 shares — an estimated $379K sold.

Point72 Asset Management first reported a position in AGL in Q3 2022 and held it in 8 quarters. The position peaked at $27.6M in Q4 2023. 194 funds tracked by Wall St. Rank hold AGL as of Q4 2025.

  • Point72 Asset Management reported no remaining Agilon Health position as of Q4 2025 after selling out during the quarter.
  • Point72 Asset Management sold 14,730 Agilon Health shares in Q4 2025, an estimated $379K.
  • Point72 Asset Management first reported a position in Agilon Health in Q3 2022 and held it in 8 quarters.
  • Point72 Asset Management's Agilon Health position peaked at $27.6M in Q4 2023.
  • 194 funds tracked by Wall St. Rank held Agilon Health as of Q4 2025.

Based on Point72 Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.